tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Matt Hewitt - 96 which are a Buy (82.76%), 20 which are a Hold (17.24%)
Analyst Matt Hewitt works at CRAIG HALLUM and is covering Healthcare, Technology sectors with 240 price targets and ratings displayed on 17 stocks.
Matt Hewitt's average stock forecast success ratio is 52.81% with an average time for price targets to be met of 121.5 days.
Most recent stock forecast was given on RGEN, Repligen at 03-Aug-2023.
Analyst best performing recommendations are on SLP (SIMULATIONS PLUS).
The best stock recommendation documented was for LGND (LIGAND PHARMACEUTICALS) at 2/4/2021. The price target of $134.12 was fulfilled within 4 days with a profit of $17.89 (15.39%) receiving and performance score of 38.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
15
$5.6 (59.57%)
17
13 days ago
5/9 (55.56%)
$3.38 (22.45%)
45
Buy
20
$10.6 (112.77%)
22
2 months 30 days ago
2/5 (40%)
$4.77 (38.33%)
80
Buy
20
$10.6 (112.77%)
6 months 7 days ago
5/5 (100%)
$3.43 (34.46%)
154
Buy
30
$20.6 (219.15%)
35
1 years 6 months 12 days ago
3/5 (60%)
$5.89 (45.10%)
183
Which stock is Matt Hewitt is most bullish on?
Which stock is Matt Hewitt is most reserved on?
What Year was the first public recommendation made by Matt Hewitt?
